Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Clinigen reiterates guidance after 'solid' first half

Wed, 12th Jan 2022 11:49
(Sharecast News) - Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of between 5% and 10% in a trading update on Wednesday.
The AIM-traded firm said that as usual, it expected to see a second-half weighting to the full-year numbers.

It said its leverage on 31 December was expected to be 2.5x, "meaningfully below" the group's temporary banking covenant of 3.5x.

"During the first half of the year we have seen a solid performance across both the services and products divisions," said group chief executive officer Shaun Chilton.

"We remain mindful of the continued prevalence of the Covid-19 Omicron variant, which has the potential to impact our principal markets.

"However, we continue to perform well on those elements within our control and remain focussed on building the lifecycle platform to service the needs of pharma companies and healthcare professionals around the globe."

At 1115 GMT, shares in Clinigen Group were down 0.54% at 917p.

Related News

IN BRIEF: UK court sanctions Titon takeover of Clinigen
1 Apr 2022

IN BRIEF: UK court sanctions Titon takeover of Clinigen

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says Thursday that its takeover by Triton Investment Management Lt...

AIM faces trading volume cliff as three most active stocks exit
7 Mar 2022

AIM faces trading volume cliff as three most active stocks exit

(Alliance News) - The three most active stocks on the AIM market in London are set to depart all at once, potentially leaving a gap in trading volume ...

TRADING UPDATES: IPF swings to profit; Seraphine lowers outlook
23 Feb 2022

TRADING UPDATES: IPF swings to profit; Seraphine lowers outlook

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

CLIN.L News

Broker tips: Weir, Rio Tinto, Polymetal, Clinigen
7 Jul 2014

Broker tips: Weir, Rio Tinto, Polymetal, Clinigen

Shares in Weir Group were making decent gains on Monday morning after the stock was upgraded from 'neutral' to 'buy' at Citigroup, which said that the...

Investec upgrades Clinigen to 'buy' after recent sell-off
7 Jul 2014

Investec upgrades Clinigen to 'buy' after recent sell-off

Investec has upgraded pharmaceutical group Clinigen from 'hold' to 'buy', saying that even on a lower target price "we think the shares offer an attra...

Clinigen To Provide Abiogen Pharma's Nerixia Through Named Patient Programme
14 Apr 2014

Clinigen To Provide Abiogen Pharma's Nerixia Through Named Patient Programme

LONDON (Alliance News) - Clinigen Group PLC said Monday that it has begun a named patient programme to provide Abiogen Pharma SpA's Nerixia to patient...

Clinigen Agrees New 4-Year GBP35 Million Debt Facility With RBS
4 Apr 2014

Clinigen Agrees New 4-Year GBP35 Million Debt Facility With RBS

LONDON (Alliance News) - Clinigen Group PLC Friday said it has secured a new four year GBP35 million multi-currency revolving credit facility, with th...

Clinigen Group agrees new credit facility with RBS
4 Apr 2014

Clinigen Group agrees new credit facility with RBS

Pharmaceutical company Clinigen Group has agreed a new four-year 35m pound multi-currency revolving credit facility with Royal Bank of Scotland (RBS)....

UK MORNING BRIEFING: Matomy Media Pulls IPO; CFOs Come And Go
4 Apr 2014

UK MORNING BRIEFING: Matomy Media Pulls IPO; CFOs Come And Go

LONDON (Alliance News) - UK shares have opened slightly higher Friday, as the market awaits US jobs figures later in the day.Matomy Media Group Ltd be...